Combined and selective monoamine oxidase inhibition in the treatment of depression in Parkinson's disease.
Jansen Steur
E N
EN
Department of Neurology, Medisch Spectrum Twente Hospital, Enschede, The Netherlands.
Ballering
L A
LA
D000328:Adult; D000368:Aged; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects; D003863:Depression / Q000188:drug therapy* / Q000209:etiology* / Q000523:psychology; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D009068:Movement / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology / Q000523:psychology*; D012642:Selegiline / Q000009:adverse effects / Q000627:therapeutic use*
D001549:Benzamides; D004338:Drug Combinations; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D020912:Moclobemide